A company at the service of patients.

A company at the service of patients.

A company at the service of patients.

From formulation to 3D printing technology. Innovation for personalized treatments.

From formulation to 3D printing technology. Innovation for personalized treatments.

The team

Our team brings together experts from the pharmaceutical industry, the hospital sector, and 3D printing specialists.

Our team brings together experts from the pharmaceutical industry, the hospital sector, and 3D printing specialists.

CEO / Co-founder

Stéphane Roulon

Stéphane Roulon

CEO / Co-founder

Stéphane Roulon

Scientific Director / Co-founder

Ian Soulairol

Ian Soulairol

Scientific Director / Co-founder

Ian Soulairol

R&D Engineer

Léna Lemierre

Léna Lemierre

R&D Engineer

Léna Lemierre

Director of Operations

Damien Stefanelli

Damien Stefanelli

Director of Operations

Damien Stefanelli

Quality Director

Manon Perez

Manon Perez

Quality Director

Manon Perez

Operational Excellence Engineer

Sarah Mathé

Sarah Mathé

Operational Excellence Engineer

Sarah Mathé

R&D Engineer

Arnaud Garrigues

Arnaud Garrigues

R&D Engineer

Arnaud Garrigues

Sales Director

Matthieu van Delft

Matthieu van Delft

Sales Director

Matthieu van Delft

Goal

Making tailor-made the new therapeutic standard

Making tailor-made the new therapeutic standard

Our history begins between the University of Montpellier and the Nîmes University Hospital. To move from research to reality, we joined forces with experts in industrial 3D printing.


Founded in 2023, MB Therapeutics now offers the major innovation that is revolutionizing the medicine of tomorrow.

Our history begins between the University of Montpellier and the Nîmes University Hospital. To move from research to reality, we joined forces with experts in industrial 3D printing.


Founded in 2023, MB Therapeutics now offers the major innovation that is revolutionizing the medicine of tomorrow.

Innovation

Because One Size Doesn't Fit All.

Because One Size Doesn't Fit All.

Ten years of expertise have led to one certainty: standard treatment has reached its limits. Every patient is unique. Their medicine must be too.

Ten years of expertise have led to one certainty: standard treatment has reached its limits. Every patient is unique. Their medicine must be too.

News

Stay informed.

LinkedIn Logo

LinkedIn

Stay informed about the latest news.

Step into the

new pharmaceutical era

Step into the

new pharmaceutical era